A Delaware federal court officially ended UroGen Pharma Ltd.'s patent infringement suit against Teva Pharmaceuticals Inc. pursuant to the parties’ stipulation of dismissal. The US District Court for ...
The next phase of Andrew Dudum’s quest to change how Americans get their health care is taking shape behind the walls of a nondescript factory, tucked off a side street in Silicon Valley. As ...
Lansing − Roughly $370.7 million designated for certain projects around the state will be returned to the general fund under a settlement deal between the Michigan House and all of the state's ...
Hims & Hers announced it will offer generic semaglutide through its direct-to-consumer virtual care platform to eligible customers in Canada, following Novo Nordisk's loss of Canadian patent ...
Hims & Hers Health (HIMS) on Thursday announced the launch of generic versions of Novo Nordisk’s (NVO) blockbuster GLP-1 therapy semaglutide through its telehealth platform in Canada. The ...
May 21 (Reuters) - Hims & Hers Health (HIMS.N), opens new tab said on Thursday it is now offering Canadians a generic version of semaglutide, the active ingredient in Novo Nordisk's (NOVOb.CO), opens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results